Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog
Authors:
- Katherine S. HansenKHKatherine S. Hansen
- Chick WeisseCWChick Weisse
- Allyson C. BerentABAllyson C. Berent
- Marilyn DunnMDMarilyn Dunn
- Ana V. CaceresACAna V. Caceres
- Kim L. ToddKTKim L. Todd
- Jeremy S. DiroffJDJeremy S. Diroff
- 15 May 2012
- journal article
- case report
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 240 (10) , 1202-1207
Abstract
Case Description—An 11-year-old spayed female Collie was evaluated because of regurgitation, dysphagia, severe ptyalism, coughing, and weight loss of approximately 12 weeks’ duration. Esophageal squamous cell carcinoma had been diagnosed prior to referral on the basis of results of radiographic and endoscopic examination and histologic evaluation of biopsy samples. A percutaneous endoscopically placed gastrostomy (PEG) tube had been inserted 2 weeks prior to referral, and the dog was being treated for infection at the gastrostomy site. Clinical Findings—Physical examination findings included marked ptyalism, stertor, and inflammation and discharge at the gastrostomy site. Treatment and Outcome—Surgical options were declined by the owner, and palliative treatment was chosen to alleviate clinical signs and facilitate PEG tube removal. With fluoroscopic guidance, a self-expanding metallic stent was placed in the esophageal lumen at the site of obstruction. Botulinum toxin A was injected into the mandibular salivary glands under ultrasonographic guidance as treatment for severe ptyalism. Following discharge, clinical improvement was reported until euthanasia for unrelated disease 12 weeks after stent placement. Necropsy revealed that the stent had not migrated and had remained patent with some tumor ingrowth but no evidence of stricture or obstruction. Clinical Relevance—Esophageal stenting effectively treated obstruction and improved clinical signs and may be beneficial for palliative treatment in other animals with malignant esophageal tumors. Although the degree to which botulinum toxin A injection into salivary glands improved clinical signs could not be determined, it may potentially be useful as adjunctive treatment to reduce severe ptyalism.Keywords
This publication has 20 references indexed in Scilit:
- Comparison of double‐layered and covered Niti‐S stents for palliation of malignant dysphagiaJournal of Gastroenterology and Hepatology, 2009
- Evidence‐Based Choice of Esophageal Stent for the Palliative Management of Malignant DysphagiaWorld Journal of Surgery, 2008
- Esophageal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2008
- Oesophageal stent insertion for palliation of dysphagia in a District General Hospital: experience from a case series of 137 patientsQJM: An International Journal of Medicine, 2008
- Endoscopic stenting-Where are we now and where can we go?World Journal of Gastroenterology, 2008
- A Randomized Prospective Comparison of Self-Expandable Plastic Stents and Partially Covered Self-Expandable Metal Stents in the Palliation of Malignant Esophageal DysphagiaAmerican Journal of Gastroenterology, 2007
- Comparison of Complications of Percutaneous Endoscopic Versus Surgically Placed Gastrostomy Tubes in 42 Dogs and 52 CatsJournal of the American Animal Hospital Association, 2006
- Natural course of inoperable esophageal cancer treated with metallic expandable stents: Quality of life and cost‐effectiveness analysisJournal of Gastroenterology and Hepatology, 2004
- Spirocercosis-associated esophageal sarcomas in dogsVeterinary Parasitology, 2004
- Palliative treatment of obstructing esophageal cancer with nitinol stents: value, safety, and long-term results.American Journal of Roentgenology, 1996